脳神経外科学大系 6 脳腫瘍I

出版社: 中山書店
著者:
発行日: 2004-09-30
分野: 臨床医学:外科  >  脳神経外科学
ISBN: 452172051X
シリーズ: 脳神経外科学大系
電子書籍版: 2004-09-30 (第1版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

59,400 円(税込)

電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

59,400 円(税込)

特記事項:
  • 【電子書籍】電子書籍版にはDVDは付属しません。予めご了承ください。

商品紹介

本大系15巻のうち2巻を占める脳腫瘍のなかの1冊。脳腫瘍の基礎(脳腫瘍の歴史、病理、免疫など)と治療法を網羅的に解説し、各疾患についてはとくに悪性脳腫瘍を中心にまとめてある。病理などの基礎は、豊富な写真や図を用い丁寧に解説し、疾患各論は、写真はもちろんのこと、動画による実際の手術手技の詳細な解説で、視覚的理解を促している。

目次

  • 脳神経外科学大系 6 脳腫瘍I

    ―目次―

    第1章 脳腫瘍総論
    第2章 脳腫瘍の診断
    第3章 脳腫瘍の治療
    第4章 脳腫瘍症例管理法
    第5章 神経上皮由来腫瘍
    第6章 血液系腫瘍
    第7章 胚細胞腫瘍

おすすめ商品

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 脳腫瘍総論

P.11 掲載の参考文献
1) 高倉公朋. 脳腫瘍病理の歴史. 日本脳腫瘍病理学会編. 脳腫瘍臨床病理カラーアトラス. 東京 : 医学書院 ; 1999. p. 1-4.
2) Bailey P, Cushing H. A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis. Philadelphia : JB Lippincott ; 1926.
5) Kernohan JW, Sayle GP. Tumors of the central nervous system. In : Atlas of Tumor Pathology, sect, X, fase. 35, 37 Washington DC : AFIP ; 1952.
6) Zulch KJ. Brain Tumors : Their Biology and Pathology. 2nd ed. New York : Springer-Verlag ; 1965.
7) Zulch KJ. Histological typing of tumours of the central nervous system. In : International Histological Classification of Tumours. No. 21 Geneva : WHO : 1979.
9) 石田陽一. 新しいWHO脳腫瘍分類の中で特記すべき項目 (腫瘍) について. 脳と神 1994 ; 46 : 1127-32.
10) 久保田紀彦. 新WHO脳腫瘍分類の改良点と問題点. 脳神外科 1995 ; 23 : 97110.
11) Kleihues P, et al. World Health Organization Classification of Tumours : Pathology & Genetics, Tumours of Central Nervous System Lyon : IARC ; 2000.
12) Oka K, et al. Detection of p53 alterations in human astrocytomas using frozen tissue sections for the polymerase chain reaction. J Neurooncol 1993 ; 16 : 125-33.
14) Kyritsis AP, et al. Mutations of p16 gene in gliomas. Oncogene 1996 ; 12 : 63-7.
16) Reifenberger J, et al. Molecular genetic analysis of olgodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994 : 145 : 1175-90.
17) Cairneross JG, et al. Aggressive oligodendroglioma : A chemosensitive tumor. Neurosurgery 1992 : 31 : 78-82.
18) 鶴尾隆. 分子標的療法の展望. 高倉公朋監修. 脳腫瘍の最新医療. 東京 : 先端医療技術研究所 ; 2003. p. 84-92.
20) 中原紀元ほか. 脳腫瘍に対する遺伝子治療. 神経の進歩 2001 ; 45 : 120-9.
29) 小林達也. II 腫瘍. 小林達也編. ガンマナイフ治療. 名古屋 : 名古屋大学出版会 ; 1998. p.15-23.
P.26 掲載の参考文献
1) Wrench M, et al. Epidemiology of primary brain tumors ; Current concepts and review of the literature. Neuro-oncol 2002 : 4 : 278-99.
2) Nichols KE, et al. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev 2001 : 10 : 83-7.
5) Grossmann SA, et al. Central nervous system cancers in the first-degree relatives and spouses. Cancer Invest 1999 ; 17 : 299-308.
9) Raaschou-Nielsen O, et al. Air pollution from traffic at the residence of children with cance.r Am J Epidemiol 2001 : 153 : 433-43.
10) Norman MA, et al. Childhood brain tumors and exposure to tobacco smoke. Cancer Epidemiol Biomarkers Prev 1996 ; 5 : 85-91.
11) Hu J, et al. Parental cigarette smoking, hard liquor consumption and the risk of childhood brain tumors : A case control study in northeast China. Acta Oncol 2000 ; 39 : 979-84.
12) Preston-Martin S, et al. Risk factors for gliomas and meningiomas in males in Los Angels County. Cancer Res 1989 : 49 : 6137-43.
19) CBTRUS (Central Brain Tumor Registry of the United States). Primary Brain Tumors in the United States : Statistical Report 1992-1997 Chicago : Central Brain Tumor Registy of the United States : 2000.
22) The Committee of Brain Tumor Registry of Japan. Report of brain tumor registy of Japan (1969-1993). 10th ed. Neurol Med Chir (Tokyo) 2000 : 40 (Suppl).
25) Curran WJ Jr, et al. Recursive partitioning analysis of prognostic factors in three oncology group malignant glioma trials. J Natl Cancer Inst 1997 : 85 : 704-10.
28) Cairneross JG, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998 ; 90 : 1473-9.
29) Ino Y, et al. Molecular subtype of anaplastic oligodendroglioma : Implications for patient management at diagnosis. Clin Cancer Res 2001 ; 7 : 839-45.
P.40 掲載の参考文献
2) Jaeckle KA. Clinical presentation and therapy of nervous system tumors. In : Bradley WG, et al, editors. Neurology in Clinical Practice. Boston : Butterworth-Heinemann ; 1991. p. 1008-30.
3) Gretter TE. Headache associated with intracranial abnormalities. Chap 27. In : Tollison CD, Kunkel RS, editors. Headache : Diagnosis and Treatment. Baltimore : Williams & Wilkins ; 1993. p. 221-5.
4) Wen PY, Black PM. Clinical presentation, evaluation, and preoperative preparation of the patient. Chap 26. In : Berger MS, Wilson CB, editors. The Gliomas. Philadelphia : WB Saunders ; 1999. p. 328-36.
5) Dunne PB. Anatomy and physiotogy of headache. Chap 3. In : Tollison CD, Kunkel RS, editors. Headache : Diagnosis and Treatment. Baltimore : Williams & Wilkins ; 1993. p. 13-8.
8) Hauser WA, Annegers JF. Epidemiology of acute symptomatic seizures. Chap 8. In : Engel J Jr, Pedley TA, editors. Epilepsy. A Comprehensive Textbook. Vol 1. Philadelphia : Lippincott-Raven ; 1998. p. 87-91.
11) Hesdorffer DC, Verity CM. Risk factors. Chap 6. In : Engel J Jr, Pedley TA, editors. Epilepsy. A Comprehensive Textbook. Vol 1. Philadelphia : Lippincott-Raven ; 1998. p. 59-67.
12) Luhdorf K, et al. Etiology of seizures in the elderly. Epilepsia 1986 ; 27 : 458-63.
13) Lieberman DM, et al. Brain tumors during the first 2 years of life. In : Albright AL, et al, editors. Principles and Practice of Pediatric Neurosurgery. New York : Thieme ; 1999. p. 463-90.
15) Ettinger AB. Structural causes of epilepsy : Tumors, cysts, stroke, and vascular malformations. Neurol Clin 1994 ; 12 : 41-56.
16) Ketz E. Brain tumours and epilepsy. In : Vinken PJ, Bruyn GW, editors. Handbook of Clinical Neurology. Vol 15. Amsterdam : North-Holland ; 1974. p. 254-69.
17) Le Blanc FE, Rasmussen T. Cerebral seizures and brain tumors. In : Vinken PJ, Bruyn GW, editors. Handbook of Clinical Neurology. Vol 16. Amsterdam : North-Holland ; 1974. p. 295-301.
18) Pace A, et al. Epilepsy and gliomas : Incidence and treatment in 119 patients. J Exp Clin Cancer Res 1998 ; 17 : 479-82.
19) Oberndorfer S, et al. The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna. Wein Klin Wochenschr 2002 : 114 : 911-6.
20) Daumas-Duport C, et al. Dysembryoplastic neuroepithelial tumor : A surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 1988 ; 23 : 545-56.
21) Daumas-Duport C. Dysembryoplastic neuroepithelial tumors. Brain Pathol 1993 ; 3 : 283-95.
22) Ildan F, et al. Intracerebral ganglioglioma : Clinical and radiological study of eleven surgically treated cases with follow-up. Neurosurg Rev 2001 ; 24 : 114-8.
24) Johnson JH, et al. Clinical outcome of pediatric gangliogliomas : Ninety-nine cases over 20 years. Pediatr Neurosurg 1997 ; 27 : 203-7.
27) Lipper MH, et al. Pleomorphic xanthoastrocytoma, a distinctive astroglial tumor : Neuroradiologic and pathologic features. AJNR Am J Neuroradiol 1993 ; 14 : 1397-404.
28) Burger PC, Scheithauer BW. Atlas of Tumor Pathology. Series 3. Fascicle 10. Tumors of the central nervous system. Washington DC : AFIP ; 1994. p. 96-102.
29) Greenberg MS. Handbook of Neurosurgery. 5th ed. Lakeland : Thieme ; 2001. p. 574-5.
30) Miller NR. Walsh and Hoyt's Clinical Neuro-Ophthalmology. Vol 1, 4th ed. Baltimore, London : Williams & Wilkins ; 1982. p. 188-9.
31) Hoyt WF, Beeston D. The Ocular Fundus in Neurologic Disease. In : A Diagnostic Manual and Stereo Atlas. St Louis : The CV Mosby ; 1966. p. 1-23.
32) Price TRP, et al. Neuropsychiatric aspects of brain tumors. In : Yudofsky SC, Hales RE, editors. Synopsis of Neuropsychiatry. Washington DC : American Psychiatric Press ; 1994. p. 361-79.
34) Berger MS, et al. Primary central nervous system tumors of the supratentorial compartment. In : Levin VA, editor. Cancer in the Nervous System. New York : Churchill Livingstone ; 1996. p. 57-126.
40) Sunada I, et al. Meningioma associated with acute subdural hematoma : Case report. Radiat Med 1998 ; 16 : 483-6.
41) Martinez-Lage JF, et al. Meningioma with haemonhagic onset. Acta Neurochir (Wien) 1991 : 110 : 129-32.
44) Strobos RJ. Temporal lobc thmors. In : Vinken PJ, Bruyn GW, editors Handbook of Clinical Neurology : Tumors of the Brain and Skull. Vol. 17. Amsterdam : North Holland ; 1974. p. 281-95.
46) Nagasaka S, et al. Simple partial seizure with a focus in Brodmann area 19 : A case report. Med Bull Fukuoka Univ 1992 : 19 : 85-8.
47) Russell A. A diencephalic syndrome of emaciation in infancy and childhood. Arch Dis Child 1951 : 26 : 274-80.
48) Miller NR. Walsh and Hoyt's Clinical Neuro-Ophthalmology. Vol 3. 4th ed Baltimore, London : Williams & Wilkins : 1988. p. 1157-9, p1354.
49) Wray SH. The neuro-ophthalmic and neurologic manifestations of pinealomas. In ; Schumidek HH, editor. Pineal Tumors. New York : Masson Publishing USA : 1977. p. 21-59.
50) Miller NR. Walsh and Hoyt's Clinical Neuro-Ophthalmology. Vol 2. 4th ed Baltimore, London : Williams & Wilkins : 1985. p. 716-9.
53) Cohen ME, Duffner PK. Tumors of the diencephalons and optic pathway. In : Cohen ME, Duffner PK, editors. Brain Tumors in Children : Principles of Diagnosis and Treatment New York : Raven Press ; 1994. p.303-28.
55) 菅野洋ほか. von Hippel-Lindau病. 脳神経 1999 ; 51 : 33-40.
56) Osbom AG. Disorders of histogenesis : Neurocutaneous syndrome. Chap 5. In : Diagnostic Neuroradiology. St Louis : Mosby ; 1994. p. 104-6.
57) Gomez MR. Tuberous Sclerosis. New York : Raven Press ; 1979. p. 11-26.
58) Gorlin RJ, et al. Hamartoneoplastic syndromes. Chap 12. Tuberous sclelosis. Syndromes of the Head and Neck 4th ed. New York : Oxford University Press : 2001. p. 488-93.
59) 原徹男ほか. 神経線維腫症 (Neurofibromatosis). 脳神経 1999 : 51 : 17-31.
60) Gorlin RJ, et al. Hamartoneoplastic syndromes. Chap 12 The neurofibromatosis (NFl Recklinghausen type, NF2 acoustic type, other types) In : Syndromes of the Head and Neck 4th ed New Yolk : Oxford University Press : 2001. p. 469-76.
61) Gorlin RJ, et al. Hamartoneoplastic syndromes. Chap 12 Turcot syndrome. In : Syndromes of the Head and Neck 4th ed New York ; Oxford University Press ; 2001. p. 440-1.
64) Williams III DW, et al. Recurrent Lhermitte-Duclos disease : Report of two cases and association with Cowden's disease. AJNR Am J Neuroradiol 1992 : 13 : 287-90.
67) Gorlin RJ, et al. Hamartoneoplastic syndromes. Chap 12 Cowden syndrome (multiple hamartoma and carcinoma syndrome, Lhermitte-Duclos syndrome). In : Syndromes of the Head and Neck 4th ed New York : Oxford University Press : 2001. p. 432-7.
69) Gorlin RJ, et al. Hamartoneoplastic syndromes. Chap 12 Gorlin (nevoid basal cell carcinoma) syndrome. In : Syndromes of the Head and Neck. 4th ed. New York : Oxford University Press : 2001. p.444-5.
71) O'Malley S, et al. Multiple neoplasms following craniospinal irradiation for medulloblastoma in patient with nevoid basal cell carcinoma syndrome : Case report. J Neurosurg 1997 : 86 : 286-8.
72) Korezak JF, et al. Nevoid basal cell carcinoma syndrome with medulloblastoma in an African-American boy : A rare case illustrating gene-environment interaction. Am J Med Genet 1997 : 69 : 309-14.
74) 塚田俊彦, 山口建. 多内分泌腺腫瘍I型. ホルモンと臨 1999 : 47 : 1069-77.
76) Gorlin RJ, et al. Syndrome affecting the skin and mucosa. Chap 13 Gorlin (nevoid basal cell carcinoma) syndrome. In : Syndromes of the Head and Neck. 4th ed. New York : Oxford University Press ; 2001. p.558-61.
P.61 掲載の参考文献
1) Kleihues P, Cavenee WK, editors. Pathology and Genetics of Tumours of the Nervous System. Lyon : International Ageney for Research on Cancer : 2000.
2) 脳腫瘍全国統計委員会・日本病理学会編. 脳腫瘍取り扱い規約. 第2版. 東京 : 金原出版 ; 2002.
4) Bigner DD, et al, editors Russel & Rubinstein's Pathology of Tumors of the Nervous System. 6th ed. London : Arnold ; 1998.
6) Preston-Martin S, et al. Risk factors for gliomas and meningiomas in males in Los Angeles County. Cancer Recs 1989 : 49 : 6137-43.
7) Zimmerman HM, Arnold H. Experimental brain tumors. I. Tu,ors produced with methycholanthrene. Cancer Res 1941 : 12 : 919-38.
11) Duffell D, et al. Neoplasms in hamsters induced by simian virus SV40 : Light and electron microscopic observations. Am J Pathol 1964 : 45 : 59-73.
12) Varakis JN, ZuRhein GM. Experimental pineocytoma of the syrian hamster induced by a human papovavirus (JC) : A light and electron microscopic study. Acta Neuropathol (Berl) 1976 : 35 : 243-64.
13) Nagashima K, et al. Induction of brain tumors by a newly isolated JC virus (Tokyo-1 stlain). Am J Pathol 1984 ; 116 : 455-63.
17) Bailey P, Cushing H. A Classification of the Tumors of the Glioma Group on a Histogenetic Basis with a Correlated Study of Prognosis. Philadelphia : Lippincott ; 1926.
18) Kernohan JW, Sayre GP. Tumors of the Central Nervous System : Fascicle 35, Atlas of Tumor Pathology. Washington DC : Armed Forces Institute of Pathology : 1952.
19) Zulch KJ. Histological Typing of Tumours of the Central Nervous System. Jeneva : World Health Organization ; 1979.
21) Kleihues P, Cavenee WK, editors. Pathology and Genetics of Tumours of the Nervous System. Lyon : International Agency for Research on Cancer : 1997.
23) Fecteau AH, et al. Peritoneal metastasis of intracranial glioblastoma via a ventriculoperitoneal shunt preventing organ retrieval : Case report and review of the literature. Clin Transplant 1998 ; 12 : 348-50.
26) Yoshida T, Nakazato Y. Characterization of refractile eosinophilic granular cells in oligodendroglial tumors. Acta Neuropathol (Berl) 2001 ; 102 : 11-9.
37) Zuppan CW, et al. Ependymoma with signet-ring cells. Ultrastruct Pathol 1994 ; 18 : 43-6.
39) Schmidbauer M, et al. Neuroepithelial and ectomesenchymal differentiation in a primitive pineal tumor ("pineal anlage tumor"). Clin Neuropathol 1989 ; 8 : 7-10.
42) Watanabe K, et al. Choroid plexus papilloma containing melanin pigment. Clin Neuropathol 1995 ; 14 : 159-61.
45) Ojeda VJ, et al. Cerebral gliomas with palisading necrosis : Glioblastoma multiforme or high grade cerebral neuroblastoma? : A light and electron microscopical study of three cases. Pathology 1981 ; 19 : 161-72.
48) Jouvet A, et al. Papillary tumor of the pineal region. Am J Surg Pathol 2003 ; 27 : 505-12.
49) Daumas-Duport C. Dysembryoplastic neuroepithelial tumours. Brain Pathol 1993 ; 3 : 283-95.
50) Iwaki T, et al. αB-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers. Am J Pathol 1993 : 143 : 487-95.
51) Katsetos CD, Krishna L. Lobar pilocytic astrocytomas of the cerebral hemispheres : I. Diagnosis and nosology. Clin Neuropathol 1994 : 13 : 295-305.
54) Alguacil-Garcia A, et al. Secretory meningioma : A distinct subtype of meningioma. Am J Surg Pathol 1986 ; 10 : 102-11.
55) Kepes JJ, et al. The role of astrocytes in the formation of carlilage in gliomas : An immunohistochemical study of four cases. Am J Pathol 1984 ; 117 : 471-83.
58) Blumcke I, et al. The CD34 epitope is expressed in neoplastic and malformative lesions associated with chronic, focal epilepsies. Acta Neuropathol (Berl) 1999 ; 97 : 481-90.
59) Katsetos CD, et al. Aberrant localization of the neuronal class IIIβ-tubulin in astrocytomas. Arch Pathol Lab Med 2001 ; 125 : 613-24.
60) Katsetos CD, et al. Localization of the neuronal class IIIβ-tubulin in oligodendrogliomas : Comparison with Ki-67 proliferative index and 1p/l9q status. J Neuropathol Exp Neurol 2002 ; 61 : 307-20.
61) Hirato J, et al. Expression of non-glial intermediate filament proteins in gliomas. Clin Neuropathol 1994 ; 13 : 1-11.
64) Lach B, et al. Angiogenic histogenesis of stromal cells in hemangioblastoma : Ultrastuctural and immunohistochemical study. Ultrastruct Pathol 1999 : 23 : 299-310.
65) Saito A, Nakazato Y. Evaluation of malignant features in oligodendroglial tumors. Clin Neuropathol 1999 ; 18 : 61-73.
68) Nakazato Y, et al. Localization of S-100 protein and glial fibrillary acidic protein-related antigen in pleomolphic adenoma of the salivary glands Lab Invest 1982 : 46 : 621-6.
72) Gerdes J, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nucleal antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991 ; 138 : 867-73.
73) Konstantinidou AE, et al. DNA topoisomerase II α expression correlates with cell proliferation but not with recurrence in intracranial meningiomas. Histopathology 2001 : 39 : 402-8.
75) Antuncs NL, et al. Intracranial Ewing sarcoma/ 'peripheral' primitive neuroectodermal tumor of dural origin with molecular genetic confirmation. J Neurooncol 2001 : 51 : 51-6.
79) Cras P, et al. γ-enolase and glial fibrillary acidic protein in nervous system tumors : An immunohistochemical study using specific monoclonal antibodies. Acta Neuropathol (Berl) 1988 : 75 : 377-84.
82) Albrecht S, et al. Transthyretin immunoreactivity in choroid plexus neoplasms and brain metastases. Mod Pathol 1991 : 4 : 610-4.
84) Arai H, et al. A novel marker of Schwann cells and myelin of the peripheral nervous system. Pathol Int 1998 : 48 : 206-14.
85) Grant JW, von Deimling A. Primary T-cell lymphoma of the central nervous system. Arch Pathol Lab Med 1990 : 114 : 24-7.
94) Nutt CL, et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003 : 63 : 1602-7.
95) Ueki K, et al. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clin Cancer Res 2002 : 8 : 196-201.
98) Biemat W, et al. Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells. J Neuropathol Exp Neurol 1995 ; 54 : 651-6.
99) Biegel JA, et al. Alterations of the hSNF5/IN11 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002 ; 8 : 3461-7.
102) 中里洋一. 現代病理学大系23c. 神経疾患 III. 東京 : 中山書店 ; 1993. p152.
103) 山口晴保. 神経特異S-100蛋白, GFA蛋白のラット神経組織, ヒト脳腫瘍組織内局在に関する免疫組織学的研究. 脳と神経 1980 : 32 : 1055-64.
P.87 掲載の参考文献
1) Kleihues P, Cavenee WK, editors. Pathology and Genetics of Tumours of the Nervous System. Lyon : IARS Press ; 2000.
2) Heldin CH. Protein tyrosine kinase receptors. Cancer Surv 1996 ; 27 : 7-24.
6) Shen CJ. Tumor surveillance via the ARF-p53 pathway. Genes Dev 1998 ; 12 : 2984-91.
9) Reifenberger G, et al. Amplification of muitiple genes from chromosomal region 12q13-14 in human malignant gliomas : Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 1994 ; 54 : 4299-303.
10) Quelle DE, et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995 ; 83 : 993-1000.
11) Schmidt EE, et al. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 1994 ; 54 : 6321-4.
12) Nishikawa R, et al. Loss of P16INK4 expression is frequent in high grade gliomas. Cancer Res 1995 ; 55 : 1941-5.
13) Costello JF, et al. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res 1996 : 56 : 2405-10.
14) Ueki K, et al. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely corelated. Cancer Res 1996 ; 56 : 150-3.
18) Wang SI, et al. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 1997 ; 57 : 4183-6.
24) Fults D, et al. Allelotype of human malignant astrocytoma. Cancer Res 1990 ; 50 : 5784-9.
25) Rubio MP, et al. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 1994 : 54 : 45-1.
26) Watanabe K, et al. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 19961. 6 : 217-23 ; discussion 23-4.
27) Ichimura K, et al. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res 2000 ; 60 : 417-24.
28) Reifenberger J, et al. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994 : 145 : 1115-90.
30) Ueki K, et al. Conelation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clin Cancer Res 2002 ; 8 : 196-201.
31) Cairncross JG, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998 ; 90 : 1473-9.
33) Ino Y, et al. Molecular subtypes of anaplastic oligodendroglioma : Implications for patient management at diagnosis. Clin Cancer Res 2001 ; 7 : 839-45.
43) Merel P, et al. Screening for germ line mutations in the NF2 gene. Genes Chromosomes Cancer 1995 ; 12 : 117-21.
48) The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993 ; 75 : 1305-15.
50) Plank TL, et al. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res 1998 ; 58 : 4766-70.
58) Hermanson M, et al. Association of loss of heterozygosity on chromosome 17p with high platelet derived growth factor α receptor expression in human malignant gliomas. Cancer Res 1996 ; 56 : 164-71.
59) Hermanson M, et al. Platelet-derived growth lactor and its receptors in human glioma tissue : Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 1992 : 52 : 3213-9.
62) Ekstrand AJ, et al. Genes for epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomas in vlvo. Cancer Res 1991 ; 51 : 2164-72.
66) Nagane M, et al. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res 1996 ; 56 : 5079-86.
70) Mishima K, et al. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor. Cancer Res 2001 : 61 : 5349-54.
73) Morrison RS. Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J Biol Chem 1991 ; 266 : 728-34.
74) Plate KH, et al. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 1993 ; 53 : 5822-7.
75) Hanis AL. Hypoxia : A key regulatory factor in tumour growth. Nat Rev Cancer 2002 ; 2 : 38-47 .
86) Nagane M, et al. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. Cancer Res 2000 ; 60 : 847-53.
95) Yuan J, et al. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-Converting enzyme. Cell 1993 ; 75 : 641-52.
96) 永根基雄. 細胞死と細胞寿命-アポトーシス, テロメア. 生塩之敬ほか編. 脳神経外科医に必要な分子細胞生物学. 東京 ; 三輪書店 ; 2001. p35-47.
101) Ellis RE, et al. Genes required for the engulfment of cell corpses during programmed cell death in Caenorhabditis elegans. Genetics 1991 : 129 : 79-94.
107) 永根基雄. 脳腫瘍の遺伝子異常. Clin Neurosci 2003 ; 21 : 518-9.
P.102 掲載の参考文献
2) Shrikant P, Benveniste N. The central nervous system as an immunocompetent organ. J Neuroimmunol 1996 ; 157 : 1819-21.
3) Gohn V, et al. Broad tumor-associated expression and recognition by tumor-derived γδT cells of MICA and MICB. Proc Natl Acad Sci USA 1999 : 96 : 6819-84.
5) Bo L, et al. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 1994 ; 51 : 135-46.
8) Chi DD, et al. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. Am J Pathol 1997 ; 150 : 2143-52.
9) Sahin U, et al. Expression of cancer testis genes in human brain tumors. Clin Cancer Res 2000 ; 6 : 3916-22.
15) Pryce G, etal. Factors controlling T cell migration cross rat cerebral endothelium in vitro. J Neuroimmunol 1991 : 75 : 84-94.
16) Irani DN. The susceptibility of mice to immune-mediated neurologic disease correlates with the degree to which their lymphocytes resist the effects of brain derived gangliosides. J Immunol 1998 ; 161 : 2746-52.
18) Tran EH, et al. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 1998 ; 161 : 3767-75.
26) Morfbrd LA, et al. T cell receptor mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. J Immunol 1997 : 159 : 4415-25.
29) Bodmer S, et al. Immunosuppression and transforming growth factor-β in glioblastoma : Preferential production of transforming growth factor-β2. J Immunol 1989 ; 143 : 3222-9.
30) Gorelik L, Flavell RA. Transforming growth factor-β in T-cell biology. Nat Rev Immunol 2002 ; 2 : 46-53.
35) Walker PR, et al. The role of Fas ligand (CD95L) in immune escape : The tumor cell strikes back. J Immunol 1997 ; 158 : 4521-4.
38) SeinoK, etal. Antitumor effect of locally produced CD95 ligand. Nat Med 1997 ; 3 : 165-70.
40) Wischhusen J, et al. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma. Cancer Res 2002 ; 62 : 2592-9.
41) Held-Feindt J, Mentlein R CD70/CD27 ligand, a member of the TNF family, is expressed in human brain tumors. Int J Cancer 2002 ; 98 : 352-6.
45) Pamey IF, et al. Human glioma immunobiology in vitro. Implications for immunogene therapy. Neurosurgery 2000 ; 46 : 1169-77.
47) Preston-Martin S, et al. Brain tumor risk in children in relation to use of electric blankets and water bed heaters : Results from the United States West Coast Childhood Brain Tumor Study. Am J Epidemiol 1996 ; 143 : 1116-22.
52) Pathell PA, et al. Primary central nervous system lymphoma in the transplant patient. Neurol Clin 1988 ; 6 : 297-303.
54) Janeway CA Jr, et al. Immunobiology : The Immune Systems in Health and Disease. New York, London : Garland Publishing. 2001. p.260.
P.113 掲載の参考文献
1) Rcport of Brain tumor Registry of Japan (1969-1996) 11th ed Neurol Med Chir (Tokyo) 2003 : 43 (Suppl).
2) Kuratsu J, Ushio Y. Epidemiological study of primary intracranial tumors in childhood. Pediatr Neurosurg 1996 : 25 : 240-7.
6) Rorke LB, Schut L. Introductory survey of pediatric brain tumors. In : McLaurin RL, et al, editors. Pediatric Neurosurgery : Surgery of the Developing Nervous System. 2nd ed Philadelphia : WB Saunders ; 1989. p. 335-7.
7) Albright AL. Brain tumors in neonates, infants, and toddlers. Contemp Neurosurg 1985 : 7 : 1-8.
11) 松谷雅生ほか. 小児の脳腫瘍. 太田富雄, 松谷雅生編. 脳神経外科. 改訂8版. 京都 : 金芳堂 ; 2001. p.452-4.
12) Cohen ME, Duffner PK. Supratcntorial hemispheric astrocytomas. In : Cohen ME, Duffner PK, editors. Brain Tumors in Children 2nd ed. New York : Raven Press : 1994. p.263-84.
13) Scott EW, Mickle JP. Pediatric diencephalic gliomas : A review of 18 cases. Pediatr Neurosci 1987 ; 13 : 225-32.
14) Balagura S, et al. Precocious pubelty of cerebral origin. Surg Neurol 1979 : 11 : 315-26.
20) Giangaspero F, et al. Medulloblastoma. In : Kleihues P, Caveneee WK, editors. Pathology and Genetics : Tumours of the Nervous System Lyon : International Ageney for Rescalch on Cancer : 2000. p. 129-37.
25) Zeltzer PM, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children : Conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 1999 ; 17 : 832-45.
26) Robenson PL, et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children : A report of the Children's Cancer Group. J Neurosurg 1998 : 88 : 695-703.
27) Cohen ME, Duffner PK. Ependymoma. In : Cohen ME, Duffner PK, editors. Brain Tumors in Children 2nd ed. New York : Raven Press : 1994. p. 219-39.
29) 松谷雅生ほか. 胚細胞腫瘍. 太田富雄, 松谷雅生編. 脳神経外科. 改訂8版. 東京 : 金芳堂 ; 2000. p. 676-93.
34) Lunsford LD, et al. Stereotactic options in the management of craniophawngioma. Pediatr Neurosurg 1994 : 21 : 90-7.
P.119 掲載の参考文献
1) Report of brain Tumor REgistry of Japan (1969-1996) 11th ed. Neurol Med Chir (Tokyo) 2003 : 43 (Suppl).
2) 久保長生, 高倉公朋. 老年者の脳腫瘍の頻度と特徴. 老と疾 1994 ; 7 : 13-6.
3) 竹島秀雄ほか. 高齢者脳腫瘍の最近の動向. Geriatric Neurosurgery 2001 ; 14 : 3-6.
4) Kuratsu J, et al. Trends in the incidence of primary intracranial tumors in Kumamoto, Japan. Int J Clin Oncol 2001 : 6 : 183-91.
7) Greig NH, et al. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 1990 ; 82 : 1621-4.
9) Lovaste MG, et al. Epidemiology of primary neoplasms : Experiment in the province of Trento (Italy), 1977-1984. Neuroepidemiology 1986 : 5 : 220-32.
14) 亀山茂樹, 田中隆―. 老年者に多い脳腫瘍の症状と診断-Meningioma (髄膜腫). 老と疾 1994 ; 7 : 22-7.
15) 間中信也. 老年者の脳腫瘍と痙攣. 老と疾 1993 ; 6 : 45-9.
16) 松本正博, 中澤省三. 老年者に多い脳腫瘍の症状と診断-Metastaic brain tumor (転移性脳腫瘍). 老と疾 1994 ; 7 : 58-64.
17) 竹下岩男, 福井仁士. 老年者に多い脳腫瘍の症状と診断-Glioblastoma multiforme (多形膠芽腫). 老と疾 1994 ; 7 : 36-41.
18) 岩佐網三ほか. 高齢者髄膜腫の治療方針と予後について. 久保田紀彦編. 髄膜腫の外科. 大阪 : メディカ出版 ; 1997. p. 210-5.
19) 泉山仁ほか. 高齢者髄膜腫の手術成績. Geriatric Neurosurgery 1998 ; 11 : 89-96.
22) 中邨裕之ほか. 高齢者転移性脳腫瘍に対するガンマナイフの治療成績. Geriatric Neurosurgery 2000 ; 13 : 67-70.
24) Nelson DF, et al. Combined modality approach to treatment of malignant gliomas-reevaluation of RTOG 7401/ECOG 1374 with long-term follow-up : A joint study of the Radiation Therapy Oncology Group and the Eastern Cooperaive Oncology Group. NCI Monogr ; 1988 : 279-84.
25) Chinot OL, et al. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer 2004 : 100 : 2208-14.
27) 泉本修一ほか. 高齢者悪性リンパ腫の予後不良因子についての検討. Geriatric Neurosurgery 2001 ; 14 : 51-55.
28) Dong Y, et al. Stereotactic radiosurgery in the treatment of primary central nervous system lymphoma. Chin Med J (Engl) 2003 : 116 ; 1166-70.
29) 寺本明, 高倉公朋. 高齢者の下垂体腺腫. 老と疾 1991 ; 4 : 84-7.
30) 魚住徹ほか. 老年者に多い脳腫瘍の症状と診断-Pituitary adenoma (下垂体腺腫). 老と疾 1994 ; 7 : 49-57.
33) 阿部琢巳ほか. 高齢者ACTH産生腺腫 (クッシング病) における経鼻的腫瘍摘出術. Geriatric Neurosurgery 1998 : 11 : 131-4.
38) 阿部琢巳. 経鼻的下垂体腫瘍摘出術-術式および工夫. 脳神外科 2003 : 31 ; 955-74.
39) 松谷雅生. 老年者の脳腫瘍の治療-放射線療法. 老と疾 1994 ; 7 : 71-6.
P.126 掲載の参考文献
3) Preston-Martin S. Descriptive epidemiology of primary tumors of the spinal cold and spinal meninges in Los Angeles County, 1972-1985. Neuroepidemiology 1990 : 9 ; 106-11.
5) Greenberg MS. 脊椎・脊髄腫瘍. 黒岩敏彦監訳. グリーンバーグ脳神経外科ハンドブック. 原著5版. 京都 : 金芳堂 ; 2002. p653-72.
6) 戸山芳昭. 髄内腫瘍の治療成績. Spine Frontier 1995 : 2 : 25-37.
7) Stein MB. Spinal tumor. In : Rowland LP, editor. Merritt's Textbook of Neurology. 7th ed. Philadelphia : Lea & Febiger ; 1984. p. 264-5.
8) Stein MB, McCormick PC. Spinal cord tumors in adults. In : Youmans JR, editor Neurological Surgery 4th ed Philadelphia : WB Saunders ; 1996. p. 3102-22.
9) Constantini S, Epstein FJ. Intraspinal tumors in infants and children. In : Youmans JR, editor Neurological Surgery. 4th ed. Philadelphia : WB Saunders : 1996. p. 3123-33.
10) 花北順哉. 硬膜内髄外腫瘍の外科 (2). 日獨医報 1999 ; 44 : 514-28.
13) Cheang CM, et al. An analysis of intraspinal tumors in south Taiwan. Kaohsiung J Med Sci 1997 : 13 : 229-36.
17) Abdel-Wahab M, et al. Prognostic factors and survival in patients with spinal cord gliomas after radiation therapy. Am J Clin Oncol 1999 : 22 : 344-51.
19) 長谷川光広ほか. 脊髄腫瘍の疫学. 脊椎脊髄 2003 ; 16 : 640-5.
20) 花北順哉. 脊椎・脊髄腫瘍. 太田富雄, 松谷雅生編. 脳神経外科. 改訂8版. 京都 : 金芳堂 ; 2001. p1487-514.
21) 岩崎喜信. 脊髄腫瘍. 阿部弘ほか編. 脳神経外科疾患の手術と適応 I. 第2版. 東京 : 朝倉書店 ; 2003. p537-51.
22) 山本隆充, 片山容―. 脊椎・脊髄手術. 片山容一, 山本隆充編. 脳神経外科手術のための神経モニタリングアトラス. 東京 : 医学書院 : 2003. p. 99-106.
23) 白土博樹, 橋本井子. 脊椎脊髄腫瘍に対する放射線治療の最前線. 脊椎脊髄 1999 ; 12 : 507-13.
24) Katagiri H, et al. Clinical results of nonsurgical treatment for spinal metastases. Int J Radiat Oncol Biol Phys 1998 : 42 : 1127-32.
P.136 掲載の参考文献
1) 佐藤一史. 頭蓋骨腫瘍. 佐藤一史編. 脳腫瘍の病理と臨床. 東京 : 診断と治療社 ; 2002. p275-9.
2) 河本圭司ほか. 頭蓋骨腫瘍分類・軟骨腫・良性軟骨芽細胞腫・軟骨肉腫. 脳神外科 2004 ; 32 : 427-35.
3) 日本整形外科学会 骨・軟部腫瘍委員会編. 整形外科・病理 悪性骨腫瘍取扱い規約. 第3版. 東京 : 金原出版 ; 2000.
4) Fletcher CDM, et al, editors. WHO Classification of Bone Tumours. In : Kleihues P, Sobin LH, series editors. Pathology & Genetics. Tumours of Soft Tissue and Bone. World Health Organization Classification of Tumours. Lyon : IARC Press : 2002. p. 225-368.
5) Unni KK, Dahlin DC. Dahlin's Bone Tumors : General Aspects and Data on 11,087 cases 5th ed. Philadelphia : Lippincott-Raven ; 1996.
7) Noterman J, et al. Monstrous skull osteomas in a probable Gardner's syndrome : Case report. Surg Neurol 1998 : 49 : 302-5.
15) 北井隆平ほか. 全身大量メソトレキセート療法とカルボプラチン動注療法が奏効した小児頭蓋骨骨肉腫の1例. 脳神外科 1995 ; 23 : 157-61.
16) 阿部琢巳ほか. 頭皮下腫瘤を形成した転移性頭蓋骨腫瘍. 脳神外科 1999 ; 51 : 353-9.
17) 前山巌. 骨転移癌の臨床像. 骨転移-病態. 診断・治療. 治療 1985 ; 2 : 7-14.
19) 案田岳夫ほか. 巨大頭皮下腫瘤を形成した多発性骨髄腫の1例. 脳神外科 1994 ; 22 : 455-60.
20) 佐藤光夫ほか. 巨大な頭部腫瘤を形成した頭蓋骨原発悪性リンパ腫の1例. 脳神外科 1993 ; 21 : 1061-4.
26) 北原功雄ほか. 側頭筋, 硬膜に浸潤をきたした好酸球性肉芽腫の1例-MRIを中心にした診断. CI研究 1994 ; 16 : 51-5.

2章 脳腫瘍の診断

P.161 掲載の参考文献
1) 今村陽子. 臨床高次脳機能評価マニュアル. 東京 : 新興医学出版社 ; 1998.
2) 田崎義昭, 斎藤佳雄. ベッドサイドの神経の診かた. 第15版. 東京 : 南山堂 ; 1993.
3) Patten J. Neurological Differential Diagnosis. London : Harold Starke : 1978.
4) 太田富雄, 松谷雅生. 脳神経外科学. 改訂第8版. 京都 : 金芳堂 ; 2000.
5) 平山恵造. 神経症候学. 東京 : 文光堂 ; 1977.
6) Plum F, Posner JB. Diagnosis of Stupor and Coma. 3rd ed. Philadelphia : FA Davis : 1980.
7) Schneider CS, et al. Correlative Neurosurgery. vol I, II. 3rd ed. Springfield : Charles C Thomas 1982.
8) Haymaker W. Bing's Local Diagnosis in Neurological Diseases. 15th ed. St Louis ; CV Mosby : 1969.
9) Needham CW. Neurological Syndromes of the Brain. Springfield : Charles C Thomas : 1973.
10) 西澤茂ほか. False localizing signとして三叉神経障害を呈した第4脳室choroid plexus papillomaの1例. 脳神外科 1989 ; 17 : 273-7.
11) 橋本信夫. 脳神経外科臨床指針. 東京 : 中外医学社 ; 2002.
12) 青木茂樹. よくわかる脳MRI. 東京 : 秀潤社 ; 1998.
13) Osborn AG. Diagnostic Neuroradiology. St Louis ; CV Mosby ; 1994.
14) Atlas SW. Magnetic Resonance Imaging of the Brain and Spine. 2nd ed. Philadelphia, New York : Lippincott-Raven ; 1996.
15) 三木幸雄. 脳. 頭頸部のMRI. 東京 : メジカルビュー社 ; 2000.
21) 三木幸雄. 脳疾患における拡散強調画像とmagnetization tansfer画像. 日磁気共鳴医会誌 1999 ; 19 : 354-65.
26) DiChiro G. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors : A powerful diagnostic and prognostic tool. Invest Radiol 1986 ; 22 : 360-71.
27) DiChiro G, et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors : PET and neuropathological studies. AJNR Am J Neuroradiol 1988 ; 8 : 1083-91.
28) Landolt AM, et al. Pituiatry Adenomas. New York : Churchill Livingstone ; 1996.
29) 影山直樹, 井村裕夫. 下垂体腺腫. 東京 : 医学書院 ; 1986.
30) 高倉公朋. 脳神経外科シリーズ-下垂体部・第3脳室腫瘍. 東京 : 現代医療社 ; 1989.
31) Wilson JD, Foster DW. Textbook of Endocrinology. 7th ed. Philadelphia : WB Saunders ; 1985.
32) DeGroot LJ, Jameson JL. Endocrinology 14th ed. Philadelphia : WB Saunders ; 2001.
33) Mazzaferri EL, Samaan N. Endocirne Tumors. Oxford : Blackwell Scientific Publications ; 1993.
36) 西澤茂ほか. 鞍上部胚細胞性腫瘍の長期成績からみた手術適応について. 小児の脳神 1993 ; 18 : 455-9.
37) Kleihues P, Cavenee WK. Pathology & Genctics : Tumours of the Nervous System. World Health Organization Classification of Tumours. Lyon : IARC Press ; 2000.
39) 平野朝雄. 神経病理を学ぶ人のために. 第2版. 東京 : 医学書院 ; 1986.
40) 平野朝雄. カラーアトラス神経病理. 第2版. 東京 : 医学書院 ; 1988.
41) 日本脳腫瘍病理学会. 脳腫瘍臨床病理カラーアトラス. 第2版. 東京 : 医学書院 ; 1999.
42) 高倉公朋. 脳神経外科シリーズ-悪性神経膠腫. 東京 : 現代医療社 ; 1989.
44) 堀嘉昭. Phacomatosisの症状と症候. クリニカルニューロサイエンス 1987 ; 9 ; 1021-4.
45) Louis DN, von Deimling A. Hereditary tumor syndrome of the nervous system : Overview and rare syndromes. Brain Pathol 1955 ; 5 : 145-51.
46) National Insitute of Health Concensus Development Conference. Neurofibromatosis. Conference Statement. Arch Neurol 1988 ; 45 : 575-8.
49) Hengstschlager M, et al. Tuberous sclerosis gene products in proliferation control. Mutat Res 2001 ; 488 : 233-9.
50) Glenn GM, et al. Von Hippel-Lindau dsease ; Clinical review and molecular genetics. Probl Urol 1990 ; 4 : 312-30.

3章 脳腫瘍の治療

P.171 掲載の参考文献
1) Lacroix, et al. A multivariate analysis of 416 patients with glioblastoma multiforme : Prognosis, extent of resection and survival. J Neurosurg 2001 ; 95 : 190-8.
3) 後藤昌三ほか. Juvenile nasopharyngeal angiofibromaに対する液体塞栓物質HEMA-MMAを用いたpre-operative embolizationの有用性. Neuro-Oncol 2001 ; 11 : 22-7.
4) 清木義勝ほか. 脳外科手術用立体視三次元ビデオ顕微鏡システムの開発と臨床応用. 脳神外科 2002 ; 30 : 601-6.
6) Sperduto PW, et al. Stereotactic radio surgery with whole brain radiation therapy improves survival in patients with brain metastases : Report of radiation therapy oncology group phase III study 95-08. Int J Radiat Oncol Biol Phys 2002 ; 54 : 3.
7) Adler JR, et al. The Neutoron 1000 : A system for frameless stercotactic radiosurgery. Neurol Surg 1994 ; 5 : 127-33.
8) 大塚隆嗣. ウサギ脳におけるLinac stereotactic irradiation後の脳血流動態および病理組織学的変化. 脳神外科 1996 ; 24 : 801-7.
10) 久保長生ほか. 神経疾患の新しい治療. 脳腫瘍の術中放射線治療. 神研の進歩 2001 ; 45 : 679-25.
11) Mizoe J, et al. Fast neutron therapy for malignant gliomas ; Results from MRS study Strahlenther Onkol 1993 ; 169 : 222-7.
12) Sweet WH. Early history of development of boron neutron capture therapy of tumors. J Neurooncol 1997 : 33 : 19-26.
13) Siu AS, et al. Comparison of miniature multileaf collimation with circular collimation for stercotactic treatment. Int J Radiat Oncol Biol Phys 1997 : 37 : 679-88.
14) Glioma Meta-analysis Trialists (GMT) Group. Chemotherapy in adult high grade glioma : A systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002 ; 359 : 1011.
15) Cairncross JG, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1988 : 90 : 1473-9.
18) 田中隆一ほか. 脳腫瘍の温熱療法-悪性グリオーマのRF組織内加温法. 加納永一監修. 集学的痛治療の研究と臨床. 東京 : 篠原出版新社 ; 2002. p. 305-13.
20) Mizuno M, et al. Growth inhibilon of glioma cells transfected with the human β-interferon gene by liposome coupled with a monoclonal antibody. Cancer Res 1990 ; 50 : 7826-9.
21) 周郷延雄ほか. 合成三次元SPECTを用いた転移性脳腫瘍のradiosurgery後極早期の効果判定, 腫瘍代謝と周囲低血流領域の数量的検討. 脳神外科 1997 ; 20 : 515-21.
22) 大石仁志ほか. 聴神経腫瘍のRadiosurgery前後における201Tl SPECTによる検討. 東邦医会誌 1995 ; 42 : 263-8.
23) 周郷延雄ほか. 3D 201TlCl SPECTによる神経膠芽腫のviabilityの画像化, SPECT及びCTの統合三次元画像を用いて. 日コンピュータ外会誌 1998 ; 6 : 49-52.
P.191 掲載の参考文献
2) 山上岩男ほか. 小脳橋角部腫瘍摘出における聴力の術中モニタリング-ABRとCNAPの比較検討. 脳神外科 2002 ; 30 : 275-82.
5) 田中隆―. 松果体部腫瘍に対するlateral-semiprone positionによるoccipital transtentorial approach. 脳神外科 1990 ; 18 : 413-22.
9) 河瀬斌. Anterior transpetrosal approach. 脳神外科 1998 ; 26 : 304-13.
12) 永谷哲也ほか. 内視鏡下経蝶形骨洞手術. 河瀬斌編. 脳神経外科advanced pracicc 3 神経内視鏡手術. 東京 : メジカルビュー社 ; 2001. p92-105.
13) 大上史朗ほか. 運動領近傍神経膠腫症例に対する運動機能温存手術-術前の運動野同定と術中モニタリングの有用性. 脳神外科 1998 ; 26 : 599-606.
P.201 掲載の参考文献
1) 宮城邦彦. 神経内視鏡の工学機能的特徴と臨床上の特徴. 大井静夫編. 神経内視鏡の基礎知識と手術手技. 東京 : 三輪書店 ; 1996. p31-7.
2) 大井静夫, 佐藤潔. Neuroendoscopic surgeryのinstrumentationと適応, 手技. 大井静夫編. 神経内視鏡の基礎知識と手術手技. 東京 : 三輪書店 ; 1996. p21-30.
3) Pemeczky A, Fries G Endoscope-assisted brain surgery : Part 1-evolution, basic concept, and current technique. Neurosurgery 42 : 1998 : 219-25.
8) Oysuki T, et al. Stereotactic endoscopic resection of angiographically occult vascular malformations. Acta Neurochir Suppl 1994 : 61 : 98-101.
12) 種子田護. 頭蓋底腫瘍の内視鏡支援手術. 嘉山孝正編. Advanced technologyを用いた脳腫瘍の外科. 大阪 : メディカ出版 ; 2001. p222-7.
14) 蛯名国彦ほか. 脳内血腫除去術における定位的脳手術用内視鏡システムの開発と臨床応用. 脳卒中の外科 1995 ; 23 : 109-15.
23) Oi S. Clinical application and future prospect of neuroendoscopic surgery. 脳と発達 31 : 1999, 299-304.
25) 永谷哲也ほか. 内視鏡下経鼻的経蝶形骨洞手術. 三宅悦夫編. 最新脳神経外科手術. 京都 : 金芳堂 ; 2003. p239-50.
P.206 掲載の参考文献
1) Lawton MT, et al. A comparative clinical evaluation of current frameless stereotactic systems ; Acuracy, performance, and surgeon preference. Perspectives in Neurological Surgery 1998 : 9 : 47-62.
6) 渡辺英寿ほか. ニューロナビゲーターと脳磁図による中心溝の決定. 脳と神経 1993 ; 45 : 1027-32.
7) Kawamata T, et al. Endoscopic augumented reality navigation system for endonasal transsphenoidal surgery to treat pituitary tumors : Technical note. Neurosurgery 2003 : 50 : 1393-7.
13) Katayatna Y, et al. Cortico-spinal direct response in humans : Identification of the motor cortex during intracranial surgery under general anesthesia. J Neurol Neurosurg Psychiatry 1998 ; 51 : 50-9.
P.210 掲載の参考文献
4) Hongo K, et al. Microscopie-manipulator system for minimally invasive neurosurgery. In : Lemke HU, et al, editors. Computer Assisted Radiology and Surgery. Amsterdam : Excerpta Medica ; 2001. p. 265-9.
5) Kan K, et al. Development of HUMAN system with three micro manipulators for minimally invasive neurosurgery. In : Lemke HU, et al, editors. Computer Assisted Radiology and Surgery. Amsterdam : Excerpta Medica ; 2001. p. 144-9.
10) 後藤哲哉ほか. NeuRobot (Microscopic-Micromanipulator System) のエチレンオキサイドガスによる滅菌について-臨床使用に向けて. 信州医誌 2002 ; 50 : 347-52.
P.223 掲載の参考文献
4) Wambersie A, Landberg T. ICRU Report 62 : Prescribing, Recording, and Reporting Photon Bearn Therapy (Supplement to ICRU Report 50). International Commission on Radiation Units and Measurements : ICRU Report 62, 1999 http://www.icru.org/n_992_4.htm
5) Huang E, et al. Intensity-modulated radiation therapy for pediatric medulloblastoma : Early report on the reduction of ototoxicity. Int J Radiat Oncol BioI Phys 2002 ; 52 (3) : 599-605.
6) Carrie C, et al. Impact of targeting deviations on outcome in medulloblastoma : Study of the French Society of Pediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys 1999 ; 45 (2) : 435-9.
8) Nishihori T, et al. Three-dimensional conformal radiotherapy for astrocytic tumors involving the eloquent area in children and young adults. J Neurooncol 2002 ; 60 (2) : 177-83.
11) Andrews DW, et al. Whole brain radiation therapy with or without stercotactic radiosurgery boost for patients with one to three brain metastases ; Phase III results of the RTOG 9508 randomised trial. Lancet 2004 ; 363 (9422) : 1665-72.
13) Adler JR Jr, et al. The Cyberknife : A fameless robotic system for radiosurgery. Stereotact Funct Neurosurg 1997 : 69 (1-4 Pt 2) : 124-8.
14) Astor MB, et al. Preclinical studies with the photon radiosurgery system (PRS). Int J Radiat Oncol Biol Phys 2000 : 47 (3) : 809-13.
P.233 掲載の参考文献
2) 星野孝夫. 悪性脳腫瘍の化学療法-そのpharmakokinetics. 脳神外科 1980 ; 8 : 1007-16.
3) Shapiro WR. Chemotherapy of malignant gliomas Studies of the BTCG. Rev Neurol 1992 : 148 : 428-34.
5) Levin VA, et al. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarvazine, lomusine, and vincristine for the treatment of anaplastic gliomas. Int J Radiat Oncol Biol Phys 1996 ; 32 : 75-83.
8) Glioma Meta-analysis Trialists (GMT) Group. Chemotherapy for high-grade glioma. The Chokurane Library. Oxford : Update Software ; 2003.
10) Cairneross JG, Macdonald DR. Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 1988 ; 23 : 360-4.
11) Cairneross JG, et al. Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 1994 ; 12 : 2013-21.
16) Weller M. Glucocorticoid treatment of primary CNS lymphoma. J Neurooncol 1999 ; 43 : 237-9.
18) Pirotte B, et al. Glucocorticoid-induced long-term remission in primary cerebral lymphoma : Case report and review of literature. J Neurooncol 1997 : 32 : 63-9.
19) DeAngelis LM. Current management of primary central nervous system lymphoma. Oncology 1995 ; 9 : 63-71.
20) Nelson DF. Radiotherapy in the treatment of primaly central nervous system lymphoma (PCNSL). J Neurooncol 1999 : 43 : 241-7.
22) 中枢神経原発悪性リンパ腫研究会 (有田憲生ほか, 事務局 : 兵庫医科大学脳神経外科) 資料.
23) 有田憲生. 中枢神経系原発悪性リンパ腫の治療. 脳外誌 2004 ; 13 : 433-40.
28) Matsutani M, et al. Combined chemotherapy and radiation therapy for CNS germ cell tumors : The Japanese experience. J Neurooncol 2001 : 54 : 311-6.
29) 松谷雅生. 厚生労働省「脳高次機能保全をはかった小児悪性脳腫瘍治療法の確立 : 12-15」班会議資料・報告.
30) Nagane M, et al. Expression of O6-methylguanine-DNA methyltransferase and chloroethyl-nitlosourea resistance of human brain tumors. Jpn J Clin Oncol 1993 : 22 : 143-9.
33) Gomi A, et al. Elevated expression of DNA polymerase β gene in glioma cell lines with acquired resistance to 1- (4-amino-2-methyl-5-pyrimidinyl) methyl-3- (2-chlorocthyl) -3-nitrosourea. Biochem Biophys Res Commun 1996 : 227 : 558-63.
36) Toth K, et al. MDRI P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. Am J Pathol 1996 ; 149 : 853-8.
37) Tsuruo T, et al. Overcoming of vineristine resistance in P388 liukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 1981 ; 41 : 1967-72.
41) Ushio Y, et al. Ventriculolumber perfusion of 3- [(4-amino-2-methyl-5-pyriminidyl) -methyl] -1- (2-chloroethyl-1-nitrosourea hydrochloride for subarachnoid dissemination of gliomas. J Neurooncol 1998 : 38 : 207-12.
44) Baranzelli MC, et al. An attempt to treat pediatric intracranial α FP and β HCG secreting germ cell tumors with chemotherapy alonc : SFOP experience with 18 cases. J Neurooncol 1998 : 37 : 229-39.
45) Ladenstein R, et al. The European experience with megadose therapy and autologous bone, marrow transplantation in solid tumors with poor prognosis Ewing sarcoma, germ celltumors and brain tumors. Wien Med Wochenschr 1995 ; 145 : 55-7.
46) Finiay JL, et al. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group. J Clin Oncol 1996 ; 14 : 2495-503.
47) Fernandez H-Hidalgo OA, et al. High-dose BCNU and autologous progenitor cell transplantation given with intra-arterial cisplatinum and simultaneous radiotherapy in the treatment of high-grade gliomas : Beneflt for selected. Patients. Bone Marrow Transplant 1996 ; 18 : 143-9.
P.238 掲載の参考文献
1) 澤村豊. サイトカインネットワーク. Clin Neurosci 2001 ; 19 : 27-9.
2) 今西二郎. サイトカインと疾患-はじめに. 今西二郎編. 別冊・医学のあゆみ. サイトカインと疾患. 東京 : 医歯薬出版 ; Jul. 2000. p. 12.
3) 小川道雄. 侵襲とサイトカイン. サイトカインによる情報伝達と臨床. 東京 : メジカルセンス ; 1997. p.8-13.
4) 松谷雅生. 脳腫瘍のBRM療法. 後藤文男ほか編. Annual Review神経 1995. 東京 : 中外医学社 ; 1995. p170-5.
5) 永井政勝. 悪性脳腫瘍に対するHuman Fibroblast Interferonの臨床的検討. 日癌治療会誌 1983 ; 18 : 60-8.
7) 永井政勝. 悪性脳腫瘍に対するBRM療法の進歩. 癌と化療 1991 ; 18 : 1880-94.
9) Yung WKA, et al. A pilot study of recombinant interferon beta (IFN-β ser) in patients with recurrent glioma. J Neurooncol 1990 ; 9 : 29-34.
10) Duff TA, et al. Phase II trial of interferon-β for treatment of recurrent glioblastoma multiforme. J Neurosurg 1986 ; 64 : 408-13.
P.244 掲載の参考文献
1) 田中隆一. 脳腫瘍の温熱療法-最近の進歩. Annual Review神経. 東京 : 中外医学社 ; 2003. p. 163-8.
2) 田中隆一ほか. 脳腫瘍の温熱療法-悪性グリオーマのRF組織内加温法. 加納永一監修. 集学的癌治療の研究と臨床. 東京 : 篠原出版新社 ; 2002. p. 305-13.
3) Takahashi H, et al. Clinical results of hyperthermia for brain tumors. In : Tanaka R, editor. Advances in Hyperthemic Oncology 2000. Niigata : Koko-do ; 2001. p. 132-6.
4) 高橋英明, 日中隆一. 7-2-2. RF組織内加温法. 高倉公朋監修. 先端医療シリーズ 18 脳神経外科-脳腫瘍の最新医療. 東京 : 先端医療技術研究所 ; 2003. p232-8.
5) Uzuka T, et al. Planning of hyperthermic treatment for malignant glioma using computer simulation. Int J Hyperthermia 2001 ; 17 : 114-22.
7) Sneed PK, et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998 ; 40 (2) : 287-95.
9) Stea B, et al. Interstitial irradiation versus interstitial thermoradiotherapy for supratentorial malignant gliomas : A comparative survival analysis. Int J Radiat Oncol Biol Phys 1994 ; 30 (3) : 591-600.
P.251 掲載の参考文献
1) Klazo I. Neuropathological aspects of brain edema. J Neulopathol Exp Neurol 1967 ; 26 : 1-14.
2) Samdani AF, et al. Brain edema A review of current ideas. Neurosurgery Quarterly 1999 ; 9 : 120-37.
3) 西川亮. 脳実質性悪性腫瘍. テント上腫瘍 (大脳). 松谷雅生ほか編. 脳神経外科周術期管理のすべて. 東京 : メジカルビュー社 ; 2000. p 110-20.
4) 水島裕ほか編著. 今日の治療薬. 東京 : 南江堂 ; 1999. p184-93.
5) 官地幸隆. グルココルチコイド製剤の体内動態と臨床応用. ホルモンと臨 1978 ; 26 : 15-22.
6) 岩瀬誠ほか. 悪心・嘔吐-5-HT3, 5-HT3に関連する薬-アザセトロン, グラニセトロンなど. 医薬ジャーナル 2000 ; 36 : 1407-13.
7) American Society of Health-Systcem Pharmacists. ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric paients receiving chemotherapy or radiation therapy or undergoing surgery. Am J Health Syst Pharm 1999 ; 56 : 729-64.
9) Systemic Treatment Disease Site Group, Cancer Care Ontario. Use of 5-HT3 receptor-antagonists in patients receiving moderately or highly emetogenic chemotherapy. Practice guideline #12-3. 2003 Jan [online update]. http://www.cancercare.on.ca/access_1108.htmからダウンロード可能.
10) Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993 ; 81 : 2844-53.
12) Ozer H, et al. 2000 update of recommendaions for the use of hematopoietic colony-stimulating factors ; Evidence-based, clinical practice guidelines. J Clin Oncol 2000 ; 18 : 3558-85.
13) 日本癌治療学会臨床試験委員会. G-CSF適正使用ガイドライン. Int J Clin Oncol 2001 ; 6 (Suppl) : 1-24.
11 別所正美. 抗癌剤とG-CSF製剤を同時投与してはいけない! 治療 (増刊号) 2003 : 86 : 796-8.
P.263 掲載の参考文献
5) Wakimoto H, et al. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4. Cancer Res 1996 : 56 : 1828-33.
6) Sobol RE, et al. Interleukin-2 gene therapy in a patient with glioblastoma. Gene Ther 1995 : 2 : 164-7.
9) Yagi K, et al. Interferon-β endogenously produced by intratumoral injection of cationic liposome-encapsulated gene ; Cytocidal effect on glioma transplanted into nude mouse brain. Biochem Mol Biol Int 1994 : 32 : 167-71.
10) Mizuno M, Yoshida J. Effect of human interferon β gene transir upon human glioma, transplanted into nude mouse brain, involves induced natural killer cells. Cancer Immunol Immunother 1998 : 47 : 227-32.
11) Natsume A. et al. Antitumor effect and cellular immunity activation by murine interferon-β gene transfer against intracerebral glioma in mouse. Gene Ther 1999 ; 6 : 1626-33.
12) Yoshida J, et al. Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human β-interferon gene using cationic liposomes. Hum Gene Ther 2004 : 15 : 77-86.
15) Tanaka T, et al. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Cancer Res 1998 : 58 : 3362-9.
16) Takayama K, et al. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ. Cancer Res 2000 : 60 : 2169-77.
17) Quattrocchi KB, et al. Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant glioma. J Neurooncol 1999 : 45 : 141-57.
21) Reeves ME, et al. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res 1996 : 56 : 5672-7.
22) Butterfield LH, et al. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adcnovirus. J Immunol 1998 : 161 : 5607-13.
23) Nakahara N, et al. Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-β gene vector and dendritic cells. Cancer Gene Ther 2003 : 10 : 549-58.
25) Takasu S, et al. Radioimmunoscinchigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor. J Neurooncol 2003 : 63 : 247-56.
28) Hunter WD, et al. Attenuated, replication-competent herpes simplex virus type 1 mutant G207 : Safety evaluation of intracerebral injection in nonhuman primates. J Virol 1999 ; 73 : 6319-26.
30) Cairncross JG, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998 : 90 : 1473-9.
31) Schmidt MC, et al. Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol 2002 : 61 : 321-8.

4章 脳腫瘍症例管理法

P.285 掲載の参考文献
2) 下山正徳. インフォームド・コンセント-歴史的展開と最近の動向. 臨科学 1997 ; 33 : 389-97.
6) 上田慶二. 治験におけるGCPの現状と問題点-GCPはどのように変わるのか. 厚生省GCP説明会. 東京 : ミクス ; 1996. p. 60-78.
7) 厚生省医薬安全局GCP研究会監修. 改訂GCPハンドブック. 東京 : 薬業時報社 ; 1997.
8) 厚生省医薬安全局GCP研究会監修. 医師のための治験ハンドブック. 改訂第4版. 東京 : エルゼビア・サイエンスミクス ; 1997.
9) 脳腫瘍全国統計委員会編. 脳腫瘍全国集計調査報告9巻. 1996. p. 67-75.
11) Reifenberger J, et al. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994 ; 145 : 1175-90.
13) Salva J, et al. Mutation of the hSNF5/INI1 gene in renal rhabdoid tumors with second primary brain tumors. J Natl Cancer Inst 2000 : 92 (8) : 648-50.
15) Yoshida J, et al. A statistical study of central neurofibromatosis in Japan. In : Ishibashi Y, Mori Y, editors. Tuberous Sclerosis and Neurofibromatosis : Epidemiology, Pathophysiology, Biology and Management New York : Elservier Science Publishers BV ; 1990. p. 315-21.